NewsRoom Articles - Page 99 of 112 - CanadianCannabisWire

TuesdayApr 24, 2018 12:21 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Begins Human Clinical Study of Its High Absorption TurboCBD Capsules

Study will measure the cardiovascular and cognitive health effects of patented DehydraTECH, its disruptive delivery technology Data generated will help company’s development of next-generation cannabinoid product formulations Chris Bunka, CEO, and John Docherty, president, to present at the ‘Next Generation Nicotine Delivery USA 2018’ conference in Atlanta on April 24 and 25 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has started a human clinical study in Europe on the health effects of its high absorption TurboCBD™ capsules. LXRP, a drug delivery platform innovator, will be conducting the study to evaluate the cardiovascular and cognitive health effects of its patented DehydraTECH™…

MondayApr 23, 2018 11:52 am

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Scores Slam Dunk with Grow Facilities in Two Largest Cannabis Markets

North American medical marijuana market estimated at $9-10 billion Over one million square feet of cannabis greenhouse space planned Signed take or pay supply agreement with world’s largest pure play cannabis company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) seems destined for a future as bright as its name. According to a recent article, titled ‘Who will Dominate California -- the World’s Largest Cannabis Market?’ (http://cnw.fm/Lc8w7), "Sunniva’s once-in-a-lifetime opportunity to become one of California’s dominant cannabis companies cannot be over-emphasized." The vertically integrated medical cannabis producer is constructing purpose built, large-scale current good manufacturing practices (cGMP) compliant greenhouse facilities in North…

FridayApr 20, 2018 12:46 pm

TransCanna™ is “One to Watch”

Creating a distribution network throughout California to serve the state’s $8.6 billion cannabis industry Plans include construction of 10,000 square foot distribution and transportation facility in Adelanto, California, with plans for several more in strategic locations around the state Holds transportation and distribution permit from Adelanto municipal government Has access to Track & Trace software platform, a requirement of California’s Bureau of Cannabis Control TransCanna™ specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna™ offers services to support every aspect of the cannabis-related eco-system; from branding and design, to…

FridayApr 20, 2018 12:02 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Receives Temporary License to Break Ground on Cannabis Cultivation Facility in California

Permanent, annual state license for this facility to be applied for within the next 120 days Production capacity projected to reach over 100,000 kg of medical cannabis per year Californian facility will provide tenancy for other licensed cannabis cultivators On April 12, 2018, Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) announced that its subsidiaries in the United States have received the necessary temporary licenses from the State of California to proceed with the construction of the company’s cultivation facilities in Cathedral City, California (http://cnw.fm/b4YDt). Licenses are temporary while the state develops permanent regulations for its newly legalized cannabis industry. Sunniva will apply…

ThursdayApr 19, 2018 11:12 am

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) is “One to Watch”

Uniquely positioned in the largest legalized medical and recreational cannabis markets – California and Canada Construction underway for a modern, agri-technology greenhouse facility in California capable of producing over 100,000 kg of premium medical cannabis annually, once phase 1 and 2 are complete Received all required California temporary licenses to cultivate, process cannabis; will apply for annual state licenses within next four months Designs completed for purpose-built current Good Manufacturing Practice (cGMP) compliant greenhouse facilities in British Columbia capable of producing 100,000 kg of premium medical cannabis per year and over 25,000 kg of trim used for extraction Application for…

WednesdayApr 18, 2018 11:29 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Significant Breakthrough with Alternative Nicotine Delivery Technology

Delivery technology already proven effective in cannabinoid delivery, now being studied in nicotine absorption Positive topline results on completion of first ingestible nicotine in vivo (animal) absorption study LXRP’s long-term strategy is to partner with leading firms in the tobacco industry, providing an additional layer of effectiveness in products to their already established consumer base Potential to revolutionize smokeless tobacco and the tobacco industry The drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has announced a significant breakthrough in alternative nicotine delivery technology. This cannabis-focused food bioscience company has a proprietary technology for improved delivery of bioactive…

TuesdayApr 17, 2018 9:00 am

Canadian Cannabis Sector Thriving Despite Slow Legalization Process

CanadianCannabisWire Editorial Coverage: Despite legislative delays, the legalization of recreational cannabis will take place in Canada, likely by the end of summer at the latest. Companies are coming to grips with the licensing process and are ready to reach this new market. One of the leaders in the new industry is Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF) (CHOOF Profile), which has gained licensing experience and developed a slick brand designed to appeal to the recreational market. Grower and seller Cronos Group, Inc. (TSX: CRON) (NASDAQ: CRON) is eyeing the international market through a cross-border deal with MedMen. Canopy Growth…

MondayApr 16, 2018 12:59 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Looking Forward to 2018 Senate Bill Addressing Regulation of Hemp

Sen. Mitch McConnell (R-KY) is a lead sponsor of ‘The Hemp Farming Act of 2018’, which would remove hemp from scheduled list of controlled substances, making it a legal crop Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is joining other leaders in the hemp industry through its anticipation of the impending Senate bill, sponsored by Majority Leader Mitch McConnell, that would remove hemp from the scheduled list of controlled substances in the U.S. and, instead, make it an agricultural commodity (http://cnw.fm/0QaGf). “It’s now time to take the final step and make this a legal crop,” Sen. McConnell said…

FridayApr 13, 2018 11:09 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Patented Drug Delivery Portfolio with New Breakthroughs

Novel drug delivery system scientifically proven to increase absorption, bioavailability and efficacy New U.S. patents awarded, strengthening company’s IP portfolio Wide variety of patent families with ranging applications Building off DehydraTECH™, its patented lipophilic drug delivery platform, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has received another new Notice of Allowance from the United States Patent and Trademark Office that protects the company’s processes for making specific compositions of matter for enhanced cannabinoid delivery (http://cnw.fm/yN7AQ). This latest announcement comes on the heels of Lexaria’s March 22, 2018, press release that announced its receipt of a Notice of Allowance for the…

WednesdayApr 11, 2018 1:47 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Provides Update on Bio-Cannabis Product Pipeline

Several proprietary products developed and ready to market in Canada, California and global markets Cannabis product sales expected to generate significant revenue Pivot’s IP portfolio includes global patents to cement its leading position in the cannabis industry On April 4, 2018, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) published an update on the advancements of its industry-leading cannabis product pipeline (http://cnw.fm/37EFo). A newly developed 1% cannabidiol (CBD) oral micelle solution, created in collaboration with the company’s German technology partner, Solmic GmbH, is ready to market. The development of two topical creams using Pivot’s patented formulation and delivery systems…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977